Silvia Camporesi

I am a bioethicist and Lecturer in Bioethics & Society at King's College London. I am interested in the intersections of genetics, ethics and society, with a special interest in sport. Originally trained as a biotechnologist in Italy, I left the bench in 2007 to pursue a PhD in Ethics & Life Sciences, a joint program of the European School of Molecular Medicine and the University of Milano. In the fall of 2009 I spent a period as a visiting PhD student at the National Cancer Institute at NIH. At that time I was sponsored by an ICRETT Transfer of Knowledge fellowship awarded by the Union for International Cancer Control, to research the ethical and regulatory issues of Phase 0 cancer trials. In 2010 I moved to London to pursue a second PhD in Philosophy of Medicine. I have been living working in London since (with a brief parenthesis for a research period at University of California San Francisco in 2011-2012). My first book, "From Bench to bedside to track & Field: the context of enhancement and its ethical relevance", has been published for University of California Medical Humanities Press in 2014. I am now working on a second book project with Mike McNamee, titled "Bioethics, Genetics & Sport" which will be published by Routledge in the Ethics & Sport Series in late 2016. In October 2013 I took up the position of Lecturer in Bioethics & Society in Department of Social Science, Health & Medicine at King's College London, where I direct the new Master’s in Bioethics & Society (launched September 2014).


Silvia Camporesi | 7 Nov 2015 |
tags: autism, eugenics, plays
The new play Tomcat tests our views about eliminating "neurodiverse" children.
 

 Search BioEdge

 Subscribe to BioEdge newsletter
rss Subscribe to BioEdge RSS feed

 Recent Posts
‘Uterine morality’: feminist eugenics in China
8 May 2021
South Caroline may replace lethal injections with firing squads for capital punishment
8 May 2021
New Zealand super heavyweight weightlifter could become first openly transgender Olympic athlete
8 May 2021
US birth rate is the lowest since records began
8 May 2021
Seattle biotech bypasses regulators to test controversial dementia treatment
8 May 2021

 Archive
May 2021 | Apr 2021 | Mar 2021 | more >>

Home | About Us | Contact Us | Privacy Policy | rss RSS | Archive | Bookmark and Share | michael@bioedge.org

BioEdge - New Media Foundation Ltd © 2004 - 2019